As the lifetime risk of breast cancer has increased, early detection methods have become integral in identifying tumors before symptoms develop. According to the American Cancer Society (ACS):

  • A woman currently living in the U.S. has a 12 percent, or 1 in 8, lifetime risk of being diagnosed with breast cancer – compared to a 1 in 11 risk in the 1970s.
  • Breast cancer typically produces no symptoms when the tumor is small and most treatable.
  • Mammography screening can detect tumors 1 to 3 years before they would have been detected if allowed to grow until symptoms develop.

Knowledge of personal risk factors and early screening are the first steps towards a higher probability of survival.

  • Women diagnosed at early stages have a higher five-year relative survival rate. According to the ACS, five-year relative survival ranges from 99 percent for localized disease (confined to the breast) to 25 percent for distant-stage disease (spread to other organs).
  • Breast cancers that can be felt when they are found tend to be larger and have likely already spread beyond the breast. Those found during screening exams are more likely to be small and confined to the breast.

Learn about your risk factors now.

Take Our FREE Health Risk Assessment Breast cancer risk estimates only available for women ages 35 to 85. Women younger than 35 and older than 85 will receive information about important risk factors to watch, but not risk estimates.
North Shore-LIJ Imaging has specialty-trained radiologists who are experts in standard and 3D mammography. Call 1-855-377-3456 to schedule a mammogram at one of our convenient locations across Long Island, Queens and Staten Island.

If you have been diagnosed with breast cancer and want to learn more about the services offered by the North Shore-LIJ Cancer Institute, visit our website for more information.

For more information and to learn about our full spectrum of women’s health services and wellness programs, please visit the Katz Institute for Women's Health website.

* As estimated by the National Cancer Institute.